Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system.
-
アブストラクト [This corrects the article DOI: 10.3389/fphar.2022.849758.]. ジャーナル名 Frontiers in pharmacology 投稿日 2022/11/29 投稿者 Guo, Haoning; Wang, Bin; Yuan, Shuying; Wu, Silin; Liu, Jing; He, Miaoquan; Wang, Jisheng 組織名 Division of Psychopharmacology, Department of Pharmacy, The Third Hospital of;Mianyang, Sichuan Mental Health Center, Mianyang, China.;Clinical Experimental Center, Jiangmen Central Hospital, Affiliated Jiangmen;Hospital of Sun Yat-Sen University, Jiangmen, China.;Department of Pathology, The Third Hospital of Mianyang, Sichuan Mental Health;Center, Mianyang, China. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/36438806/ -
お問合わせ
検索
メルマガ登録
